These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19403421)

  • 21. [Role of vascular endothelial growth factor overexpression in ovarian tumor invasion and mechanism].
    Lu Y; Zhang A; Wang S; Li J; Wang C; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):294-7. PubMed ID: 12133405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of phosphatase of regenerating liver cell-3 gene silence by RNA interference on the expression of matrix metalloproteinases-2,-9 in human colon cancer cells].
    Fan Y; Zhang YL; Zheng S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):477-81. PubMed ID: 18803055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing 1 gene in ovarian cancer cell lines].
    Liu GY; Qu QX; Mi RR; Qi J
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):339-42. PubMed ID: 16762192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
    Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
    Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
    Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
    Xu KS; Wang HF; Qian W; Wang BH
    Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.
    Sun Y; Liu M; Yang B; Lu J; Li B
    Cancer Invest; 2008 Dec; 26(10):984-9. PubMed ID: 19093256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect of siRNA on heparanase expression and invasion ability of gastric cancer cells: an in vitro experiment].
    Zhang Y; Wang ZN; Zhang X; Xu HM; Jiang L; Luo Y; Xing LL; Xu MD; Li J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1717-20. PubMed ID: 17825158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of RNAi-mediated gene silencing of C-erbB-2 on proliferation of lung adenocarcinoma cell line calu-3].
    Ren SH; Zhang W; Qu P; Liu Y; Wang JW; Zhang L
    Ai Zheng; 2005 Oct; 24(10):1173-8. PubMed ID: 16219128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of small interfering RNA specific for Her-2 gene on biological behavior of ovarian carcinoma cell].
    Zhou Y; Ling B; Feng DQ; Cheng ZX; Shen GD; Gao T; Shi YY; Wang MM; Zhao WD; Zhu HP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):830-3. PubMed ID: 17327114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of CXCR4 inhibited by RNA interference on metastasis and invasion of breast cancer cell in vitro].
    Zhang SC; Qiao L; Gao H
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):473-5. PubMed ID: 17686306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The experimental investigation of the invasion and growth of laryngeal cancer by matrix metalloproteinase-2 and matrix metalloproteinase-9 gene silence together].
    Sun YN; Yang BF; Liu M; Guo YL; Tian LL; Jiao H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):36-9. PubMed ID: 18346378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.
    Leong CT; Ong CK; Tay SK; Huynh H
    Oncogene; 2007 Feb; 26(6):870-80. PubMed ID: 16862170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV‑3 human ovarian carcinoma cells.
    Lu YM; Rong ML; Shang C; Wang N; Li X; Zhao YY; Zhang SL
    Oncol Rep; 2013 Mar; 29(3):1133-9. PubMed ID: 23292493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
    Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.